These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30586138)

  • 1. Association Between Antithrombotic Medication Use After Bioprosthetic Aortic Valve Replacement and Outcomes in the Veterans Health Administration System.
    Bravata DM; Coffing JM; Kansagara D; Myers J; Murphy L; Homoya BJ; Perkins AJ; Snow K; Quin JA; Zhang Y; Myers LJ
    JAMA Surg; 2019 Feb; 154(2):e184679. PubMed ID: 30586138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic Strategies After Bioprosthetic Aortic Valve Replacement: A Systematic Review.
    Papak JN; Chiovaro JC; Noelck N; Healy LD; Freeman M; Quin JA; Paynter R; Low A; Kondo K; McCarty OJT; Kansagara D
    Ann Thorac Surg; 2019 May; 107(5):1571-1581. PubMed ID: 30458159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
    ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial.
    Rafiq S; Steinbrüchel DA; Lilleør NB; Møller CH; Lund JT; Thiis JJ; Køber L; Olsen PS
    Thromb Res; 2017 Feb; 150():104-110. PubMed ID: 27914653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral microembolization after bioprosthetic aortic valve replacement: comparison of warfarin plus aspirin versus aspirin only.
    Al-Atassi T; Lam K; Forgie M; Boodhwani M; Rubens F; Hendry P; Masters R; Goldstein W; Bedard P; Mesana T; Ruel M
    Circulation; 2012 Sep; 126(11 Suppl 1):S239-44. PubMed ID: 22965989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement in Elderly Patients: A Single-Center Experience.
    Lee SI; Lee KS; Kim JB; Choo SJ; Chung CH; Lee JW; Jung SH
    Ann Thorac Cardiovasc Surg; 2017 Jun; 23(3):128-134. PubMed ID: 28367855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic strategy after bioprosthetic aortic valve replacement in patients in sinus rhythm: evaluation of guideline implementation.
    van der Wall SJ; Umans VA; Schotten J; Keijzers M; Wolterbeek R; Jansen EK; Huisman MV; Vonk AB
    Eur J Cardiothorac Surg; 2016 Apr; 49(4):1157-63. PubMed ID: 26233944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.
    Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED;
    J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation After Biological Aortic Valve Replacement: Is There An Optimal Regimen?
    Owais T; Rouman M; Breuer M; Hüter L; Fuchs J; Lauer B; Kuntze T
    J Heart Valve Dis; 2016 Mar; 25(2):139-144. PubMed ID: 27989055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial.
    Colli A; Mestres CA; Castella M; Gherli T
    J Heart Valve Dis; 2007 Nov; 16(6):667-71. PubMed ID: 18095518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacement.
    Christersson C; James SK; Lindhagen L; Ahlsson A; Friberg Ö; Jeppsson A; Ståhle E
    Heart; 2020 Jun; 106(11):838-844. PubMed ID: 31757813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study.
    Gherli T; Colli A; Fragnito C; Nicolini F; Borrello B; Saccani S; D'Amico R; Beghi C
    Circulation; 2004 Aug; 110(5):496-500. PubMed ID: 15289387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses: A Meta-Analysis.
    Riaz H; Alansari SA; Khan MS; Riaz T; Raza S; Luni FK; Khan AR; Riaz IB; Krasuski RA
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):294-302. PubMed ID: 27166205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonusefulness of Antithrombotic Therapy After Surgical Bioprosthetic Aortic Valve Replacement.
    Gryaznov AA; Saeyeldin A; Abdelbaky M; Zafar MA; Tanweer M; Papanikolaou D; Imran M; Li Y; Ziganshin BA; Elefteriades JA
    Am J Cardiol; 2020 Aug; 129():71-78. PubMed ID: 32605717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Antithrombotic Strategies in Chinese Patients in Sinus Rhythm after Bioprosthetic Mitral Valve Replacement: Early Outcomes from a Multicenter Registry in China.
    Zhang H; Dong Y; Ao X; Fu B; Dong L;
    Cardiovasc Drugs Ther; 2021 Feb; 35(1):1-10. PubMed ID: 32940891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The difficult choice of antithrombotic therapy after bioprosthetic aortic valve implantation: aspirin, warfarin, or both?].
    Marullo AG; Iacò AL; Calafiore AM
    G Ital Cardiol (Rome); 2013 Apr; 14(4):246-7. PubMed ID: 23567764
    [No Abstract]   [Full Text] [Related]  

  • 17. Antithrombotic management after aortic valve replacement with biological prosthesis: a meta-analysis.
    Uimonen M; Kuitunen I; Ponkilainen V; Mennander A; Mattila MS
    J Cardiothorac Surg; 2024 Jun; 19(1):385. PubMed ID: 38926789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital readmission rates are similar between patients with mechanical versus bioprosthetic aortic valves.
    Kilic A; Bianco V; Gleason TG; Aranda-Michel E; Chu D; Navid F; Althouse AD; Sultan I
    J Card Surg; 2018 Sep; 33(9):497-505. PubMed ID: 30091187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks and benefits of concurrent treatment with antiplatelet and anticoagulation therapy in post-op bioprosthetic aortic valve replacement patients.
    Yaghi C; Masson R; Yamada K; Zhu S; Fong C; Shirazi A; LaPunzina P; Mok K
    J Card Surg; 2021 Mar; 36(3):879-885. PubMed ID: 33442916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of apixaban versus aspirin for the prevention of latent bioprosthetic aortic valve thrombosis: study protocol for a prospective randomized trial.
    Kopjar T; Gasparovic H; Paar MH; Lovric D; Cerina P; Tokic T; Milicic D
    Trials; 2024 May; 25(1):324. PubMed ID: 38755709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.